REVIEW PAPER
Molecular aspects of hereditary complement component C5 deficiency in humans
More details
Hide details
1
Department of Medical Biology, School of Public Health, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Poland, Poland
Submission date: 2024-04-03
Final revision date: 2024-04-25
Acceptance date: 2024-04-27
Online publication date: 2024-07-15
Corresponding author
Hanna Szymańska
Department of Medical Biology, School of Public Health, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Żołnierska 14C, 10-561 Olsztyn, Poland
Pol. Ann. Med. 2024;31(2):139-144
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The complement system plays a key role in the host defense against pathogens. The deficiency of complement components predisposes the system to recurrent infections and autoimmune diseases. In particular, serum C5 deficiency (C5D) may be serious for human health, because this protein plays a key role in controlling infections, mainly with Neisseria spp.
Aim:
The aim of this article is to present the structure and function of the human C5 gene encoding complement component C5, with particular regard to the molecular characteristics of the mutations causing hereditary complement C5 deficiency.
Material and methods:
This article is based on the available literature. A total of 35 articles were included in the study.
Results and discussion:
Based on the literature review, it was shown that C5 mediates inflammatory processes and bacterial cytolysis. The cause of hereditary C5 deficiency in humans is inefficient or reduced serum C5 biosynthesis, due to mutations in the C5 gene. This quantitative and functional C5 deficiency is associated with recurrent Neisseria spp. infections, the lack of bactericidal activity and an impaired ability of serum to induce chemotaxis. The molecular characterization of previously described C5D-related mutations in the human C5 gene has been performed, and the clinical presentation of some molecularly examined C5D probands has also been discussed.
Conclusions:
The deficiency of C5 protein, which bridges innate and adaptive immunity, is related with 18 different mutations in the C5 gene found in over 30 families of various origins. Screening for complement defects seems particularly important, especially in asymptomatic relatives of probands.
FUNDING
None declared.
CONFLICT OF INTEREST
None declared.
REFERENCES (35)
1.
Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I – molecular mechanisms of activation and regulation. Front Immunol. 2015;6:262.
https://doi.org/10.3389/fimmu.....
2.
2 Pfarr N, Prawitt D, Kirschfink M, et al. Linking C5 deficiency to an exonic splicing enhancer mutation. J Immunol. 2005;174(7):4172–4177.
https://doi.org/10.4049/jimmun....
3.
López-Lera A, Garrido S, de la Cruz RM, Fontán G, López-Trascasa M. Molecular characterization of three new mutations causing C5 deficiency in two non-related families. Mol Immunol. 2009;46(11–12):2340–2347.
https://doi.org/10.1016/j.moli....
4.
Arnaout R, Al Shorbaghi S, Al Dhekri H, et al. C5 complement deficiency in a Saudi family, molecular characterization of mutation and literature review. J Clin Immunol. 2013;33(4):871–875.
https://doi.org/10.1007/s10875....
5.
Lappegård KT, Christiansen D, Pharo A, et al. Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature. Proc Natl Acad Sci U S A. 2009;106(37):15861–15866.
https://doi.org/10.1073/pnas.0....
6.
Franco-Jarava C, Comas D, Orren A, Hernández-González M, Colobran R. Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease. Clin Exp Immunol. 2017;189(2):226–231.
https://doi.org/10.1111/cei.12....
7.
Snyderman R, Durack DT, McCarty GA, Ward FE, Meadows L. Deficiency of the fifth component of complement in human subjects. Clinical, genetic and immunologic studies in a large kindred. Am J Med. 1979;67(4):638–645.
https://doi.org/10.1016/0002-9....
8.
Delgado-Cerviño E, Fontán G, López-Trascasa M. C5 complement deficiency in a Spanish family. Molecular characterization of the double mutation responsible for the defect. Mol Immunol. 2005;42(1):105–111.
https://doi.org/10.1016/j.moli....
9.
Aguilar-Ramirez P, Reis ES, Florido MP, et al. Skipping of exon 30 in C5 gene results in complete human C5 deficiency and demonstrates the importance of C5d and CUB domains for stability. Mol Immunol. 2009;46(10):2116–2123.
https://doi.org/10.1016/j.moli....
10.
Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol. 2005;23:821–852. doi:10.1146/annurev.immunol.23.021704.115835.
11.
Cheng SC, Sprong T, Joosten LA, et al. Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs. Eur J Immunol. 2012;42(4):993–1004.
https://doi.org/10.1002/eji.20....
12.
Futoma-Kołoch B, Bugla-Płoskońska G. Efektywność bakteriobójczego działania surowicy wynikająca z obecności układu dopełniacza i lizozymu wobec bakterii, które unikają odpowiedzi immunologicznej organizmu [The efficiency of the bactericidal action of serum raised by complement and lysozyme against bacteria which avoid the immunological response of higher organisms]. Postepy Hig Med Dosw (Online). 2009;63:471–484.
13.
Heesterbeek DA, Bardoel BW, Parsons ES, et al. Bacterial killing by complement requires membrane attack complex formation via surface-bound C5 convertases. EMBO J. 2019;38(4):e99852.
https://doi.org/10.15252/embj.....
14.
Carney DF, Haviland DL, Noack D, Wetsel RA, Vik DP, Tack BF. Structural aspects of the human C5 gene. Intron/exon organization, 5'-flanking region features, and characterization of two truncated cDNA clones. J Biol Chem. 1991;266(28):18786–18791.
15.
Haviland DL, Haviland JC, Fleischer DT, Hunt A, Wetsel RA. Complete cDNA sequence of human complement pro-C5. Evidence of truncated transcripts derived from a single copy gene. J Immunol. 1991;146(1):362–368.
16.
Karp CL, Grupe A, Schadt E, et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol. 2000;1(3):221–226.
https://doi.org/10.1038/79759.
17.
Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med. 2007;357(12):1199–1209.
https://doi.org/10.1056/NEJMoa....
18.
Schejbel L, Fadnes D, Permin H, Lappegård KT, Garred P, Mollnes TE. Primary complement C5 deficiencies - molecular characterization and clinical review of two families. Immunobiology. 2013;218(10):1304–1310.
https://doi.org/10.1016/j.imbi....
19.
Sanal O, Loos M, Ersoy F, Kanra G, Seçmeer G, Tezcan I. Complement component deficiencies and infection: C5, C8 and C3 deficiencies in three families. Eur J Pediatr. 1992;151(9):676–679.
https://doi.org/10.1007/BF0195....
20.
Wetsel RA, Fleischer DT, Haviland DL. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'-exon. J Biol Chem. 1990;265(5):2435-2440.
22.
Kohler PF, Müller-Eberhard HJ. Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults. J Immunol. 1967;99(6):1211–1216.
23.
Frank MM. Complement in control of infectious agents. In Long SS, Prober CG, Fischer M. Principles and practice of pediatric infectious diseases, 5th ed., Elsevier, 2018: p. 624–628.
24.
Hellerud BC, Aase A, Herstad TK, et al. Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies. Infect Immun. 2010;78(2):802–809.
https://doi.org/10.1128/IAI.01....
25.
El Sissy C, Rosain J, Vieira-Martins P, et al. Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies. Front Immunol. 2019;10:1936.
https://doi.org/10.3389/fimmu.....
26.
Miller ME, Nilsson UR. A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). N Engl J Med. 1970;282(7):354–358.
https://doi.org/10.1056/NEJM19....
27.
Jacobs JC, Miller ME. Fatal familial Leiner's disease: a deficiency of the opsonic activity of serum complement. Pediatrics. 1972;49(2):225–232.
28.
Rosenfeld SI, Leddy JP. Hereditary deficiency of fifth component of complement (C5) in man. J. Clin. Invest. 1974;53:67A.
29.
Asghar SS, Venneker GT, van Meegen M, Meinardi MM, Hulsmans RF, de Waal LP. Hereditary deficiency of C5 in association with discoid lupus erythematosus. J Am Acad Dermatol. 1991;24(2 Pt 2):376–378.
https://doi.org/10.1016/0190-9....
30.
Schoonbrood TH, Hannema A, Fijen CA, Markusse HM, Swaak AJ. C5 deficiency in a patient with primary Sjögren's syndrome. J Rheumatol. 1995;22(7):1389–1390.
31.
Marujo F, Costa LC, Duarte R, et al. Invasive meningococcal disease unraveling a novel mutation in the C5 gene in a Portuguese family. Pediatr Infect Dis J. 2019;38(4):416–418.
https://doi.org/10.1097/INF.00....
32.
Wang X, Fleischer DT, Whitehead WT, et al. Inherited human complement C5 deficiency. Nonsense mutations in exons 1 (Gln1 to Stop) and 36 (Arg1458 to Stop) and compound heterozygosity in three African-American families. J Immunol. 1995;154(10):5464–5471.
33.
Colobran R, Franco-Jarava C, Martín-Nalda A, et al. Novel mutations causing C5 deficiency in three North-African families. J Clin Immunol. 2016;36(4):388–396.
https://doi.org/10.1007/s10875....
34.
Owen EP, Würzner R, Leisegang F, et al. A complement C5 gene mutation, c.754G>A:p.A252T, is common in the Western Cape, South Africa and found to be homozygous in seven percent of Black African meningococcal disease cases. Mol Immunol. 2015;64(1):170–176.
https://doi.org/10.1016/j.moli....
35.
Orren A, Owen EP, Potter PC, Leisegang F, Morgan BP, Wurzner R. Complement component 5 deficiency (C5D) in South Africa. Mol. Immunol. 2011;48:1863.